Literature DB >> 6254335

Natural killer activity in peripheral lymphocyte population following local radiation therapy.

H Blomgren, E Baral, F Edsmyr, L E Strender, B Petrini, J Wasserman.   

Abstract

The natural killer (NK) activity of peripheral lymphocytes against 51Cr-labelled Chang or K562 cells was tested using a 4 h release assay before and after postoperative radiation therapy for mammary carcinoma. NK activity against K562 was significantly reduced at completion of therapy (a total target dose of 45.0 Gy) and restituted 3 to 4 months later. NK activity against Change cells exhibited a slight but non-significant decline at completion of therapy followed by an overshoot 3 to 4 months later. The frequency of Fc-IgG receptor bearing lymphocytes was decreased at completion of therapy and largely restored after 3 to 4 months.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254335     DOI: 10.3109/02841868009130145

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  6 in total

1.  Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer.

Authors:  E Tichatschek; C C Zielinski; C Müller; P Sevelda; E Kubista; K Czerwenka; J Spona; H Wolf; M M Eibl
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 2.  The biology of the human natural killer cell.

Authors:  J C Roder; H F Pross
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

3.  The effect of radiotherapy on the natural killer (NK)-cell activity of cancer patients.

Authors:  K McGinnes; J Florence; R Penny
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

4.  Decreased production of soluble interleukin 2 receptor by phytohaemagglutinin-stimulated peripheral blood mononuclear cells in patients with breast cancer after adjuvant therapy.

Authors:  C C Zielinski; C Müller; E Tichatschek; P Aiginger
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

Review 5.  Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response.

Authors:  Elisa C Toffoli; Abdolkarim Sheikhi; Yannick D Höppner; Pita de Kok; Mahsa Yazdanpanah-Samani; Jan Spanholtz; Henk M W Verheul; Hans J van der Vliet; Tanja D de Gruijl
Journal:  Cancers (Basel)       Date:  2021-02-09       Impact factor: 6.639

Review 6.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.